Addressing the need for rapid treatment of agitation in schizophrenia and bipolar disorder: focus on inhaled loxapine as an alternative to injectable agents

Addressing the need for rapid treatment of agitation in schizophrenia and bipolar disorder: focus on inhaled loxapine as an alternative to injectable agents

Leslie CitromeDepartment of Psychiatry and Behavioral Sciences, New York Medical College, Valhalla, NY, USAAbstract: Agitation (excessive motor or verbal activity) can be associated with schizophrenia or bipolar mania, and can further escalate into aggressive behavior and potentially lead to injurie...

Full description

Bibliographic Details
Main Author:	Citrome L
Format:	Article
Language:	English
Published:	Dove Medical Press 2013-05-01
Series:	Therapeutics and Clinical Risk Management
Online Access:	http://www.dovepress.com/addressing-the-need-for-rapid-treatment-of-agitation-in-schizophrenia--a13091

Similar Items

Examining the safety, efficacy, and patient acceptability of inhaled loxapine for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults
by: Faden J, et al.
Published: (2019-08-01)

Inhaled Loxapine for the Management of Acute Agitation in Bipolar Disorder and Schizophrenia: Expert Review and Commentary in an Era of Change
by: Bruno Pacciardi, et al.
Published: (2019-02-01)

Inhaled Loxapine for the Treatment of Psychiatric Agitation in the Prehospital Setting: A Case Series
by: Armando Cester-Martínez, et al.
Published: (2017-10-01)

Rationale and design of the PLACID study: a randomised trial comparing the efficacy and safety of inhaled loxapine versus IM aripiprazole in acutely agitated patients with schizophrenia or bipolar disorder
by: L. San, et al.
Published: (2017-04-01)

<b>New drugs for the treatment of agitation in schizophrenia: a systematic review and meta-analysis of inhaled loxapine and infused sodium nitroprusside
by: Fernanda Stumpf Tonin, et al.
Published: (2017-05-01)

The Role of Inhaled Loxapine in the Treatment of Acute Agitation in Patients with Psychiatric Disorders: A Clinical Review
by: Domenico de Berardis, et al.
Published: (2017-02-01)

Managing Agitation Associated with Schizophrenia and Bipolar Disorder in the Emergency Setting
by: Scott L. Zeller, MD, et al.
Published: (2016-03-01)

Loxapine to control agitation during weaning from mechanical ventilation
by: Stéphane Gaudry, et al.
Published: (2017-09-01)

Characterizing the experience of agitation in patients with bipolar disorder and schizophrenia
by: Jenna Roberts, et al.
Published: (2018-04-01)

Patient perspectives in the development and use of long-acting antipsychotics in schizophrenia: focus on olanzapine long-acting injection
by: Leslie Citrome
Published: (2009-11-01)

Loxapine in patient with clozapine-resistant psychosis
by: Audu, A., et al.
Published: (2021)

The Management of Psychomotor Agitation Associated with Schizophrenia or Bipolar Disorder: A Brief Review
by: Maurizio Pompili, et al.
Published: (2021-04-01)

Effects of asenapine on agitation and hostility in adults with acute manic or mixed episodes associated with bipolar I disorder
by: Citrome L, et al.
Published: (2017-12-01)

Update on schizophrenia and bipolar disorder: focus on cariprazine
by: Roberts RJ, et al.
Published: (2016-07-01)

Development of novel loxapine derivatives as a new class of antibacterial agent against intracellular Salmonella Typhimurium
by: Yi-Lun Wu, et al.
Published: (2019)

Repurposing An Antipsychotic Drug, Loxapine, As A Host-Targeting Antibacterial Agent Against Salmonella Typhimurium Infection
by: Ching-Yi Yang, et al.
Published: (2017)

Loxapine-Induced Priapism: A Case Report and Review of the Literature on Antipsychotic-Induced Priapism
by: Alexandra L. Dodd, et al.
Published: (2021-01-01)

Assessing effectiveness of aripiprazole lauroxil vs placebo for the treatment of schizophrenia using number needed to treat and number needed to harm
by: Citrome L, et al.
Published: (2019-09-01)

Role of sublingual asenapine in treatment of schizophrenia
by: Citrome L
Published: (2011-05-01)

Loxapine and Cyproheptadine Combined Limit Clozapine Rebound Psychosis and May Also Predict Clozapine Response
by: Lila Aboueid, et al.
Published: (2016-01-01)

Effectiveness and safety of oral olanzapine treatment transitioned from rapid-acting intramuscular olanzapine for agitation associated with schizophrenia
by: Katagiri H, et al.
Published: (2018-04-01)

Safety and effectiveness of rapid-acting intramuscular olanzapine for agitation associated with schizophrenia – Japan postmarketing surveillance study
by: Katagiri H, et al.
Published: (2018-01-01)

Schizophrenia relapse, patient considerations, and potential role of lurasidone
by: Citrome L
Published: (2016-08-01)

Loxapine, an antipsychotic drug, suppresses intracellular multiple-antibiotic-resistant Salmonella enterica serovar Typhimurium in macrophages
by: Ching-Yi Yang, et al.
Published: (2019-08-01)

A survey of caregiver burden in those providing informal care for patients with schizophrenia or bipolar disorder with agitation: results from a European study
by: Sophee Blanthorn-Hazell, et al.
Published: (2018-02-01)

Development and validation of an HPLC-UV method for analysis of methylphenidate hydrochloride and loxapine succinate in an activated carbon disposal system
by: Pooja Bakshi, et al.
Published: (2018-12-01)

An Evidence-Based Review of OLZ/SAM for Treatment of Adults with Schizophrenia or Bipolar I Disorder
by: Citrome L, et al.
Published: (2021-09-01)

Cariprazine for acute and maintenance treatment of adults with schizophrenia: an evidence-based review and place in therapy
by: Citrome L
Published: (2018-10-01)

A randomized, double-blind, placebo-controlled study of rapid-acting intramuscular olanzapine in Japanese patients for schizophrenia with acute agitation
by: Katagiri Hideaki, et al.
Published: (2013-01-01)

Neurobiology of schizophrenia and bipolar disorder
by: Mφller Hans-Jórgen
Published: (2008-04-01)

Investigation of Relationship between Schizophrenia and Bipolar Disorders with Infections Agents
by: Cansu ÖNLEN
Published: (2017-09-01)

Alternative pharmacological treatment options for agitation in Alzheimer’s disease
by: Francesco Panza, et al.
Published: (2015-11-01)

Persistent akathisia masquerading as agitated depression after use of ziprasidone in the treatment of bipolar depression
by: Penders TM, et al.
Published: (2013-04-01)

Schizophrenia in a member of the family: Burden, expressed emotion and addressing the needs of the whole family
by: Gian Lippi
Published: (2016-08-01)

Electroencephalographic Microstates in Schizophrenia and Bipolar Disorder
by: Fanglan Wang, et al.
Published: (2021-02-01)

Brexpiprazole for the maintenance treatment of adults with schizophrenia: an evidence-based review and place in therapy
by: Ward K, et al.
Published: (2019-01-01)

Prehospital use of ketamine for rapid sedation of the acutely agitated patient
by: Correll, David
Published: (2021)

Focus on Innuvair® Inhaler for Asthma
by: J. Van Schoor
Published: (2018-07-01)

Patient perspectives on use of long-acting antipsychotics in bipolar disorder: focus on risperidone injection
by: L Samalin, et al.
Published: (2010-08-01)

Loxapine for Treatment of Patients With Refractory, Chemotherapy-Induced Neuropathic Pain: A Prematurely Terminated Pilot Study Showing Efficacy But Limited Tolerability
by: Sven Schmiedl, et al.
Published: (2019-07-01)